Published in Infect Immun on October 28, 2013
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev (2014) 1.28
Antifungal innate immunity: recognition and inflammatory networks. Semin Immunopathol (2014) 0.91
A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections. Antimicrob Agents Chemother (2015) 0.85
Innate Immune Signaling Activated by MDR Bacteria in the Airway. Physiol Rev (2016) 0.81
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism. Semin Immunopathol (2014) 0.81
Biological and pathological activities of interleukin-22. J Mol Med (Berl) (2016) 0.80
Modeling mucosal candidiasis in larval zebrafish by swimbladder injection. J Vis Exp (2014) 0.79
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection. J Cyst Fibros (2016) 0.78
Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. Virulence (2016) 0.77
Candida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of Eicosanoids. Front Physiol (2016) 0.76
Pathogenesis of Fungal Infections in Cystic Fibrosis. Curr Fungal Infect Rep (2016) 0.75
Galactomannan and Zymosan Block the Epinephrine-Induced Particle Transport in Tracheal Epithelium. PLoS One (2015) 0.75
Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans. Sci Rep (2016) 0.75
Association of Mucosal Organisms with Patterns of Inflammation in Chronic Rhinosinusitis. PLoS One (2015) 0.75
The Best Defense is a Good (Protease) Offense: How Pseudomonas aeruginosa Evades Mucosal Immunity in the Lung. Virulence (2017) 0.75
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem (2002) 14.34
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med (2008) 9.05
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Human IL-17: a novel cytokine derived from T cells. J Immunol (1995) 6.65
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
Structure and signalling in the IL-17 receptor family. Nat Rev Immunol (2009) 6.38
The diploid genome sequence of Candida albicans. Proc Natl Acad Sci U S A (2004) 6.34
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol (1999) 6.15
The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol (2010) 6.02
Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol (2000) 5.74
Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol (2010) 5.63
Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res (2010) 5.23
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol (2011) 4.64
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20
IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol (2004) 3.84
The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe (2009) 3.07
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J (2004) 2.70
Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol (2011) 2.70
The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol (2011) 1.76
IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol (2010) 1.76
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect (2006) 1.68
The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care (2008) 1.67
Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol (2006) 1.63
Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells. Microbes Infect (2005) 1.62
Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect Immun (2009) 1.52
Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am J Respir Crit Care Med (2008) 1.44
IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J Immunol (2011) 1.37
Innate immune responses to Pseudomonas aeruginosa infection. Microbes Infect (2011) 1.33
Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk. Curr Opin Microbiol (2004) 1.25
Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol (2012) 1.18
NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection. J Immunol (2008) 1.12
Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice. FEMS Immunol Med Microbiol (2011) 1.10
An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity. Infect Immun (2008) 1.03
Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association? Med Mal Infect (2013) 1.02
Inhaled innate immune ligands to prevent pneumonia. Br J Pharmacol (2011) 0.97
Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa. Shock (2008) 0.96
Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Crit Care (2011) 0.95
Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats. Shock (2006) 0.94
Role of type 1 natural killer T cells in pulmonary immunity. Mucosal Immunol (2013) 0.87
Severe Candida spp. infections: new insights into natural immunity. Int J Antimicrob Agents (2010) 0.86
FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin. Exp Lung Res (2009) 0.86
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med (2015) 3.92
Cell lineage reconstruction of early zebrafish embryos using label-free nonlinear microscopy. Science (2010) 2.78
The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology (2002) 2.58
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intensive Care Med (2015) 2.25
Predictive computation of genomic logic processing functions in embryonic development. Proc Natl Acad Sci U S A (2012) 2.11
Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis (2003) 1.91
Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa. Anesthesiology (2007) 1.73
Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm (2006) 1.70
Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol (2006) 1.63
Predictors of extubation failure in patients with chronic obstructive pulmonary disease. J Crit Care (2006) 1.54
Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med (2006) 1.45
Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon. Infect Immun (2002) 1.40
Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J Immunol (2005) 1.38
Postoperative ischemic bronchitis after lymph node dissection and primary lung cancer resection. Ann Thorac Surg (2011) 1.38
Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem (2012) 1.35
Asthmatic bronchial epithelium activated by the proteolytic allergen Der p 1 increases selective dendritic cell recruitment. J Allergy Clin Immunol (2005) 1.32
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 1.29
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial. Crit Care Med (2012) 1.28
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res (2010) 1.27
Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun (2009) 1.26
Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis (2008) 1.25
Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol (2002) 1.23
Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol (2004) 1.20
Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res (2009) 1.19
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care (2010) 1.17
Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro. Infect Immun (2003) 1.16
Functional disomy of the Xq28 chromosome region. Eur J Hum Genet (2005) 1.15
Identification of a new family of genes involved in beta-1,2-mannosylation of glycans in Pichia pastoris and Candida albicans. J Biol Chem (2008) 1.14
Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells. J Immunol (2010) 1.14
Effect of isthmus anatomy and ablation catheter on radiofrequency catheter ablation of the cavotricuspid isthmus. Circulation (2004) 1.14
Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol (2002) 1.12
Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology (2006) 1.12
Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells. Infect Immun (2007) 1.12
Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pathog (2007) 1.12
Introduction of SARS in France, March-April, 2003. Emerg Infect Dis (2004) 1.10
Involvement of CCL18 in allergic asthma. J Immunol (2006) 1.09
Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol (2002) 1.07
Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and post-natal growth retardation and intractable feeding difficulties. Eur J Hum Genet (2005) 1.07
Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol (2009) 1.07
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Crit Care Med (2011) 1.07
Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med (2006) 1.06
Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals. Med Mycol (2012) 1.06
Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol (2003) 1.05
Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology (2007) 1.05
Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med (2003) 1.05
Chemical extraction versus direct smear for MALDI-TOF mass spectrometry identification of anaerobic bacteria. Anaerobe (2012) 1.03
Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol (2007) 1.03
Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol (2006) 1.01
Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol (2004) 1.01
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector. Mol Ther (2006) 1.01
Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol (2008) 1.00
Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction. Infect Immun (2011) 1.00
Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cell Microbiol (2009) 0.99
Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol (2004) 0.99
Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect Dis (2006) 0.97
Scavenger receptors in human airway epithelial cells: role in response to double-stranded RNA. PLoS One (2012) 0.97
GPI7 affects cell-wall protein anchorage in Saccharomyces cerevisiae and Candida albicans. Microbiology (2002) 0.97
Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J Leukoc Biol (2003) 0.96
A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med (2008) 0.96
Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts. Diagn Microbiol Infect Dis (2006) 0.96
Role of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability. Am J Respir Cell Mol Biol (2008) 0.96
Fluorescence in situ hybridization sperm analysis of six translocation carriers provides evidence of an interchromosomal effect. Fertil Steril (2005) 0.95
Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation. J Biol Chem (2004) 0.95
Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Crit Care (2011) 0.95
Candida albicans phospholipomannan promotes survival of phagocytosed yeasts through modulation of bad phosphorylation and macrophage apoptosis. J Biol Chem (2003) 0.95
Beta-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes. Infect Immun (2008) 0.95
NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol (2006) 0.95
Relevance of serologic studies in inflammatory bowel disease. Curr Gastroenterol Rep (2004) 0.94
Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J Immunol (2008) 0.94
Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Am J Respir Crit Care Med (2014) 0.93
Pro-inflammatory properties for thiazolidinediones. Biochem Pharmacol (2004) 0.93
Candida albicans cell wall glycosylation may be indirectly required for activation of epithelial cell proinflammatory responses. Infect Immun (2011) 0.93
Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test. J Clin Microbiol (2009) 0.93
Identification of biofilm-associated cluster (bac) in Pseudomonas aeruginosa involved in biofilm formation and virulence. PLoS One (2008) 0.92
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology (2009) 0.92
Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression. BMC Microbiol (2008) 0.91
Dual mechanism controls asymmetric spindle position in ascidian germ cell precursors. Development (2010) 0.91